Positron Corporation (POSC)

[eztradin]

POSC definitely has the technology. I've been following this story before most people and when it was a sub penny several years ago. The progress has been slow. I really hope this company can succeed, and it does look like sales are ramping up, but without specific dollars mentioned in a P.R., shareholders can only guess until the financial reports come out.

I'm just showing where they're right now based on their last 10Q.

Here's something from the latest 10Q:

Customer deposits represent amounts paid to the Company by customers for devices in advance of manufacturing completion and/or shipment of the device to the customer. Deposit amounts may vary depending on the contract. Included in customer deposits at March 31, 2010 were deposits of approximately $669,000 from a customer that had placed an order for five Nuclear Pharm-Assist™ systems. As of the date of this report, there can be no assurance that this customer will fulfill its order for these devices. Accordingly, deposits related to this customer have been reclassified from unearned revenue to customer deposits. Also included in customer deposits at March 31, 2010, are $396,000 of deposits for sales of Attrius™ Cardiac PET systems.

Then, today's P.R.:

Due to Demand Positron is Increasing Production of Attrius(TM) PET Scanners

INDIANAPOLIS, Jul 08, 2010 (BUSINESS WIRE) -- Positron Corporation (OTCBB:POSC), a molecular imaging and solutions company specializing in Nuclear Cardiology and a leader in Cardiac PET, announces that due to a greater demand for the Attrius(TM) PET scanner, the Company has recently begun increasing production capacities with its joint venture, Neusoft Positron Medical Systems.
Positron's award-winning, cardiac optimized PET scanner, the Attrius(TM), is the only advanced, dedicated, cost-effective PET scanner in the marketplace. The introduction of the Attrius(TM) last year has generated excitement throughout the cardiac molecular imaging industry. Facilitated by the increase in reimbursement for cardiac PET and an industry-wide movement to better and more efficient medical imaging, Positron's Attrius(TM) has seen unprecedented interest and sales. As a result of the recent sales, Positron has met its six month projections and has to increase production earlier than previous estimations. Based on Positron's current sales and a more robust pipeline, the Company believes that they will surpass 2010 and 2011 targets of approximately 70 systems in the next 18 months.

Maybe, someone knows what the unit sell is on this Attrius Cardiac Pet system, and then multiply
by 70 and should give you a ball park sales amount.

From above:

Included in customer deposits at March 31, 2010 were deposits of approximately $669,000 from a customer that had placed an order for five Nuclear Pharm-Assist™ systems.

If these were the one's they were selling 70 of, we could find the estimated sales:

$669,000/5 x 70=$9,366,000

I'm not sure if these sell more than the Attrius or less, and one could probably find out if they dig into the filings or past P.R.'s

Long day, hitting the hay.